Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank

From Oncology Today with Dr Neil Love Dr. Neil Love

Drs Neeraj Agarwal, Emmanuel Antonarakis, Karim Fizazi and Susan Slovin discuss the current and future role of PARP inhibitors in the management of prostate cancer.

CME information and select publications here.

Community discussion

Join the conversation

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical Investigator Think Tank

You May Also Like

Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra

Trent Loos Podcast

The 365 Days of Astronomy

Real Ghost Stories Online

Breaking Down: Collapse

The Grave Talks | Haunted, Paranormal & Supernatural

The Biotech Startups Podcast

The Best of Coast to Coast AM

Eye On The Sky

Мослекторий